Shares of Novo Nordisk (NVO) trading in New York are down $5.22, or 6%, to $81.95 in the pre-market session.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk reports REDEFINE 2 trial of CagriSema achieved primary endpoint
- Hims & Hers Stock (HIMS) Soars on Plans to Shutter Acne Treatment Unit
- Novo Nordisk (NVO) Warns of Drug Shortages if Tariffs Are Imposed
- BofA says injunction denial ‘indirect negative’ for Hims & Hers
- Hims & Hers lower after judge denies compounders’ motion for injunction